REFERENCES
1.Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H, Neselioglu S, et
al. A novel oxidative stress marker in acute myocardial infarction;
thiol/disulphide homeostasis. Am J Emerg Med . 2015; 33: 1567-71.
2.Demirbag R, Rabus B, Sezen Y, Taskın A, Kalaycı S. The plasma and
tissue oxidative status in patients with coronary artery disease:
oxidative stress and coronary artery disease. Türk Göğüs Kalp
Damar Cerrahisi Dergisi . 2010;18:79-82.
3.Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J et al.
The cardiovascular disease continuum validated: clinical evidence of
improved patient outcomes part i: pathophysiology and clinical trial
evidence (risk factors through stable coronary artery disease).Circulation . 2006;114: 2850-70.
4.Topal FE, Karakaya Z, Akyol PY, Payza U, Çalışkan M, Topal F.
Increased thiol/disulphide ratio in patients with ST elevation-acute
coronary syndromes. Cukurova Medical Journal . 2019;44(Suppl
1):20-25.
5.Sigala F, Kotsinas A, Savari P, et al. Oxidized LDL in human carotid
plaques is related to symptomatic carotid disease and lesion
instability. J Vasc Surg. 2010;52:704–13.
6.Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species
produced by macrophage-derived foam cells regulate the activity of
vascular matrix metalloproteinases in vitro. Implications for
atherosclerotic plaque stability. J Clin Invest. 1996;98:2572–9.
7.Vichova T, Motovska Z. Oxidative stress: Predictive marker for
coronary artery disease, Exp Clin Cardiol. 2013; 18(2): e88–e91.
8.Droge W. Free Radicals in the Physiological Control of Cell Function.Physiol Rev. 82: 47–95, 2002; 10.1152/physrev.00018.2001.
9. Erel O, Neselioglu S. A novel and automated assay for
thiol/disulphide homeostasis. Clinical biochemistry.2014;47(18):326-32.
10. Otal Y, Demircan S, Sener A, Alısık M, Tanrıverdi F, Haydar FGE, et
al. Acute Renal Failure and Thiol-Disulfide Homeostasis. J Nephrol
Ther . 2018;08(03):8–11.
11.Ercan Haydar FG, Otal Y, Şener A, Pamukçu Günaydın G, İçme F, Atmaca
Temrel T, et al. The thiol-disulphide homeostasis in patients with acute
pancreatitis and its relation with other blood parameters. Ulus
Travma ve Acil Cerrahi Derg . 2020;26(1):37–42.
12. Erel O, Erdoğan S. Thiol-disulfide homeostasis : an integrated
approach with biochemical and clinical aspects. Turk J Med Sci .
2020;50:1728–38.
13. Biswas S, Chida AS, Rahman I. Redox modifications of protein-thiols:
Emerging roles in cell signaling. Biochem Pharmacol .
2006;71(5):551–64.
14. Circu M, Aw T. Reactıve oxygen specıes, cellular redox systems and
apoptosıs. Free radic biol med . 2010;48(6):749–62.
15.Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin
changes - review and clinical implications. Clin Chem Lab Med.2011; 49: 177-84
16. Gaze DC. Ischemia modified albumin: a novel biomarker for the
detection of cardiac ischemia. Drug Metab Pharmacokinet. 2009;
24: 333-41.
17. Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J,
Mookadam F, et al. Capability of ischemia-modified albumin to predict
serious cardiac outcomes in the short term among patients with potential
acute coronary syndrome. CMAJ . 2005; 172: 1685-90.
18. Filippi C, Yoon S, Ro A. Early detection of myocardial ischemia by a
novel blood based biomarker: the kinetics of ischemia modified albumin.J Am Coll Cardiol. 2003; 41:6.
19. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R,
et al. Ischemia Modified Albumin for the assessment of patients
presenting to the emergency department with acute chest pain but normal
or nondiagnostic 12-lead electrocardiograms and negative cardiac
troponin T. Int J Cardiol. 2004; 97: 297-301.
20. Thielmann M, Pasa S, Holst T, Wendt D, Dohle DS, Demircioglu E, et
al. Heart-type fatty acid binding protein and ıschemia-modified albumin
for detection of myocardial ınfarction after coronary artery bypass
graft surgery. Ann Thorac Surg . 2017;104(1):130-7. doi:10.1016/j.
athoracsur.2016.10.051.
21. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of ischemia
modified albumin a new biochemical marker of myocardial ischemia, in the
early diagnosis of acute coronary syndromes. Emerg Med J . 2004;
21: 29-34.
22.Desborough JP. The stress response to trauma and surgery. Br J
Anaesth 2000;851:109–17.
23.Laffey JG, Boylan JF, Cheng DCH. The systemic inflammatory response
to cardiac surgery: implications for the anesthesiologist.Anesthesiology . 2002;97:215–52.
24. Galter D, Mıhm S, Dro¨ Ge W. Distinct effects of glutathione
disulphide on the nuclear transcription factor kappa B and the activator
protein-1. Eur J Biochem . 221: 639–648, 1994.
25. Tunon MJ, Garcia-Mediavilla MV, Sanchez-Campos S, Gonzalez-Gallego
J. Potential of flavonoids as antiinflammatory agents: modulation of
pro-inflammatory gene expression and signal transduction pathways.Curr Drug Metab . 2009;10(3):25671.
26. Shaulian E, Karin M. AP-1 in cell proliferation and survival.Oncogene. 2001;20(19):2390400.
27. Giuliani C, Bucci I and Napolitano G (2018) The Role of the
Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and
Cancer. Front. Endocrinol . 9:471. doi: 10.3389/fendo.2018.00471.
28.Hehner SP, Breıtkreutz R, Shubınsky G, UnsoelD H, Schulze-Osthoffk,
Schmıtz ML, Dro¨ GE W. Enhancement of T cell receptor signaling by a
mild oxidative shift in the intracellular thiol pool. J Immunol .
2000;165: 4319–4328.
29. Ellman G, Lysko H. A precise method for the determination of whole
blood and plasma sulfhydryl groups. Anal Biochem.1979;93(1):98–102.
30. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt- albumin
binding and its potential as a marker for myocardial ischemia - a
preliminary report. J Emerg Med . 2000;19:311-5.
31. Seyda Efsun Ozgunay, Kadir Kaan Ozsin, Yasemin Ustundag, Derya
Karasu1, Buket Ozyaprak, Burak Balcı, Ozcan Erel, Senol Yavuz. The
Effect of Continuous Ventilation on Thiol-Disulphide Homeostasis and
Albumin- Adjusted Ischemia-Modified Albumin During Cardiopulmonary
Bypass, Braz J Cardiovasc Surg . 2019;34(4):436-43.
32. Hatemi AC, Çeviker K, Tongut A, Özgöl İ, Mert M, Kaya A. Oxidant
status following cardiac surgery with phosphorylcholine-coated
extracorporeal circulation systems. Oxid Med Cell Longev .
2016;2016:3932092.
33. Kundi H, Erel Ö, Balun A, Çiçekçioğlu H, Cetin M, Kiziltunç E, et
al. Association of thiol/disulfide ratio with SYNTAX score in patients
with NSTEMI. Scand Cardiovasc J . 2015; 49: 95-100.
34. Bulent Bilir, Dursun Cayan Akkoyun, Murat Aydın, Demet Ozkaramanlı
Gur, Hasan Degirmenci, Neslihan Albayrak et all. Association of coronary
artery disease severity and disulphide/native thiol ratio. Eur J
Gen Med . 2017;14(2):30-33.
35. Altıparmak IH, Erkuş ME, Sezen H, Demirbağ R, Günebakmaz O, Kaya Z
et al. The relation of serum thiol levels and thiol/disulphide
homeostasis with the severity of coronary artery disease. Kardiol
Pol. 2016; 74: 1346-53.
36. Adly AAM, ElSherif NHK, Ismail EAR, Ibrahim YA, Niazi G, Elmetwally
SH. Ischemia-modified albumin as a marker of vascular dysfunction and
subclinical atherosclerosis in β-thalassemia major. Redox Rep .
2017;22(6):430-8.
37. Chi D, Chen C, Shi Y, Shi Y, Wang W, Ma Y. et al. Ventilation during
cardiopulmonary bypass for prevention of respiratory insufficiency: a
meta-analysis of randomized controlled trials. Medicine .
2017;96(12):e6454.
38. Fujita M, Komeda M, Hasegawa K, Kihara Y, Nohara R, Sasayama S.
Pericardial fluid as a new material for clinical heart research.Int J Cardiol . 2001;77:113 – 8.
39. Ben-Horin S, Shinfeld A, Kachel E, Chetrit A, Livneh A (2005) The
composition of normal pericardial fluid and its implications for
diagnosing pericardial effusions. Am J Med. 118(6):636–640
40. Karahan SC, Koramaz I, Altun G, Uçar U, Topbaş M, Menteşe A, et al.
Ischemia-modified albumin reduction after coronary bypass surgery is
associated with the cardioprotective efficacy of cold-blood cardioplegia
enriched with N-acetylcysteine: a preliminary study. Eur Surg
Res. 2010;44:30-6.